248 related articles for article (PubMed ID: 21083021)
1. Prognostic molecular markers in myelodysplastic syndromes.
Neukirchen J; Haas R; Germing U
Expert Rev Hematol; 2009 Oct; 2(5):563-75. PubMed ID: 21083021
[TBL] [Abstract][Full Text] [Related]
2. Is International Prognostic Scoring System (IPSS) still standard in predicting prognosis in patients with myelodysplastic syndrome? External validation of the WHO Classification-Based Prognostic Scoring System (WPSS) and comparison with IPSS.
Park MJ; Kim HJ; Kim SH; Kim DH; Kim SJ; Jang JH; Kim K; Kim WS; Jung CW
Eur J Haematol; 2008 Nov; 81(5):364-73. PubMed ID: 18637029
[TBL] [Abstract][Full Text] [Related]
3. Clinical features of prognostic significance in myelodysplastic patients with normal karyotype at high risk of transformation.
Breccia M; Mancini M; Nanni M; D'Elia GM; Carmosino I; Latagliata R; Sarlo C; Mandelli F; Alimena G
Leuk Res; 2005 Jan; 29(1):33-9. PubMed ID: 15541472
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the prognosis of patients with myelodysplastic syndromes.
Aul C; Giagounidis A; Germing U; Ganser A
Ann Hematol; 2002 Sep; 81(9):485-97. PubMed ID: 12373348
[TBL] [Abstract][Full Text] [Related]
5. Evolving classifications of the myelodysplastic syndromes.
Komrokji RS; Bennett JM
Curr Opin Hematol; 2007 Mar; 14(2):98-105. PubMed ID: 17255786
[TBL] [Abstract][Full Text] [Related]
6. Overview of myelodysplastic syndromes.
Beris P; Georgiou G
Semin Hematol; 2012 Oct; 49(4):287-94. PubMed ID: 23079058
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic tools in the indications for allogeneic stem cell transplantation in myelodysplastic syndromes.
Bacher U; Haferlach C; Kröger N; Schnittger S; Kern W; Wiedemann B; Zander AR; Haferlach T
Biol Blood Marrow Transplant; 2010 Jan; 16(1):1-11. PubMed ID: 20053328
[TBL] [Abstract][Full Text] [Related]
8. International MDS risk analysis workshop (IMRAW)/IPSS reanalyzed: impact of cytopenias on clinical outcomes in myelodysplastic syndromes.
Kao JM; McMillan A; Greenberg PL
Am J Hematol; 2008 Oct; 83(10):765-70. PubMed ID: 18645988
[TBL] [Abstract][Full Text] [Related]
9. Significant correlation between the degree of WT1 expression and the International Prognostic Scoring System Score in patients with myelodysplastic syndromes.
Cilloni D; Gottardi E; Messa F; Fava M; Scaravaglio P; Bertini M; Girotto M; Marinone C; Ferrero D; Gallamini A; Levis A; Saglio G;
J Clin Oncol; 2003 May; 21(10):1988-95. PubMed ID: 12743153
[TBL] [Abstract][Full Text] [Related]
10. Comparison of five prognostic scoring systems, the French-American-British (FAB) and World Health Organization (WHO) classifications in patients with myelodysplastic syndromes: Results of a single-center analysis.
Müller-Berndorff H; Haas PS; Kunzmann R; Schulte-Mönting J; Lübbert M
Ann Hematol; 2006 Aug; 85(8):502-13. PubMed ID: 16715299
[TBL] [Abstract][Full Text] [Related]
11. Classification and scoring systems in myelodysplastic syndromes: a retrospective analysis of 311 patients.
Navarro I; Ruiz MA; Cabello A; Collado R; Ferrer R; Hueso J; Martinez J; Miguel A; Orero MT; Pérez P; Nolasco A; Carbonell F
Leuk Res; 2006 Aug; 30(8):971-7. PubMed ID: 16423393
[TBL] [Abstract][Full Text] [Related]
12. Prognostic scoring systems for risk assessment in myelodysplastic syndromes.
Greenberg PL; Sanz GF; Sanz MA
Forum (Genova); 1999; 9(1):17-31. PubMed ID: 10101208
[TBL] [Abstract][Full Text] [Related]
13. Prognostic scoring systems in MDS.
Germing U; Kündgen A
Leuk Res; 2012 Dec; 36(12):1463-9. PubMed ID: 22980036
[TBL] [Abstract][Full Text] [Related]
14. A comparative review of classification systems in myelodysplastic syndromes (MDS).
Bennett JM
Semin Oncol; 2005 Aug; 32(4 Suppl 5):S3-10. PubMed ID: 16085011
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors and scoring systems in myelodysplastic syndromes.
Sanz GF; Sanz MA; Greenberg PL
Haematologica; 1998 Apr; 83(4):358-68. PubMed ID: 9592987
[TBL] [Abstract][Full Text] [Related]
16. World Health Organization classification in combination with cytogenetic markers improves the prognostic stratification of patients with de novo primary myelodysplastic syndromes.
Bernasconi P; Klersy C; Boni M; Cavigliano PM; Calatroni S; Giardini I; Rocca B; Zappatore R; Caresana M; Dambruoso I; Lazzarino M; Bernasconi C
Br J Haematol; 2007 May; 137(3):193-205. PubMed ID: 17408458
[TBL] [Abstract][Full Text] [Related]
17. [Significance, diagnosis and prognosis in the cytogenetic analysis in acute leukemias and myelodysplastic syndromes].
Jotterand Bellomo M
Ther Umsch; 1996 Feb; 53(2):103-10. PubMed ID: 8629259
[TBL] [Abstract][Full Text] [Related]
18. Single nucleotide polymorphism array karyotyping: a diagnostic and prognostic tool in myelodysplastic syndromes with unsuccessful conventional cytogenetic testing.
Arenillas L; Mallo M; Ramos F; Guinta K; Barragán E; Lumbreras E; Larráyoz MJ; De Paz R; Tormo M; Abáigar M; Pedro C; Cervera J; Such E; José Calasanz M; Díez-Campelo M; Sanz GF; Hernández JM; Luño E; Saumell S; Maciejewski J; Florensa L; Solé F
Genes Chromosomes Cancer; 2013 Dec; 52(12):1167-77. PubMed ID: 24123380
[TBL] [Abstract][Full Text] [Related]
19. [Expression of differentiation antigens on bone marrow myeloid cells of the patients with myelodysplastic syndromes and its clinical significances].
Li LJ; Fu R; Wang HQ; Yue LZ; Liu H; Wang J; Wang HL; Ruan EB; Qu W; Liang Y; Wang GJ; Wang XM; Liu H; Song J; Wu YH; Xing LM; Guan J; Shao ZH
Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(10):672-7. PubMed ID: 20450725
[TBL] [Abstract][Full Text] [Related]
20. [Cytogenetics of myelodysplastic syndromes].
Laï JL; Fenaux P
Pathol Biol (Paris); 1997 Sep; 45(7):550-5. PubMed ID: 9404478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
